ARK Genomic Revolution ETF vs Omnicom Group Inc. — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Omnicom Group Inc. trades at $85.74 (market cap $23.58B). The key difference: Omnicom Group Inc. pays a 3.72% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | OMC | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $44.55 | $86.22 |
52-Week Low | $24.02 | $67.27 |
Market Cap | — | $23.58B |
Enterprise Value | — | $31.66B |
Dividend Yield | — | 3.72% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →